Welcome Providers!

The Diabetes Testing Centers™ (DTC) began 15 years ago with a focus on providing comprehensive and accurate diabetes-related assessments that empower patients and healthcare providers to manage diabetes from 'head-to-toes' using evidence-based products and services. DTC installs diagnostic centers inside primary care and specialty medical clinics. This allows healthcare providers to offer on-site testing, ensuring patients receive timely, and personalized care plans within the convenience of their existing healthcare settings. 

Today, DTC serves as a revenue-generation arm of the largest non-acute care Group Purchasing Organization (GPO) in the US, with a membership base of over 20,000 clinics. Since its inception, DTC has advocated for medical providers to adopt a 'diabetes-centric' philosophy by incorporating its non-invasive health risk assessments into each medical clinic to improve patient outcomes and practice finances. Recognizing the interconnected nature of diabetes, DTC has expanded its scope over the years to offer additional assessments for conditions affecting people with diabetes. These include medical weight loss, lower-extremity amputation prevention, cardiovascular disease, sleep medicine, and more. DTC is now better equipped to provide comprehensive care that not only manages diabetes but also supports the general patient population, including those who may not have diabetes. Screen. Test. Treat.

Keep Patients In-House and Boost Revenue

Diabetes-Centric Philosophy

The 'diabetes-centric' philosophy is not a one-size-fits-all approach. DTC offers a comprehensive range of assessments, enabling providers to manage diabetes holistically, from early detection and routine monitoring to the management of complex, multi-system complications. This adaptable approach empowers clinics of all sizes to focus on managing and treating diabetes-related conditions effectively. Larger clinics can offer a wider array of diagnostic tests and treatments, while smaller clinics can concentrate on patient education and simple biometric monitoring like A1C tests. This flexibility ensures that all aspects of diabetes care are addressed, regardless of clinic size. 

The primary goal of this philosophy is to efficiently manage all facets of a patient's health related to diabetes. Even if a clinic cannot implement the full range of recommended assessments, focusing on specific areas—such as heart attack/stroke, or peripheral arterial disease, or painful neuropathy—can still significantly impact patient outcomes and generate substantial revenue. For instance, a portable handheld AI fundus camera can autonomously diagnose diabetic retinopathy in under 60 seconds, eliminating the need for specialist referrals and closing care gaps.

Adopting the 'diabetes-centric' philosophy not only improves patient care but also provides a financial boost for clinics of all sizes. This increase in revenue enhances a clinic's ability to offer superior patient services and ensures a strong return on investment. All assessments are eligible for Medicare and Medicaid reimbursements, making them accessible to a wide patient base and providing a compelling reason for clinics to embrace this approach.

Strengthen Your Practice. 

Customized Your Testing

At Diabetes Testing Centers™ (DTC), we offer more than just advanced health-risk assessments—we provide a low-risk, high-reward opportunity to invest in your own success. By integrating DTC's customized diagnostics into their practices, providers are not only enhancing patient care but also significantly elevating their professional value and growth with zero down or minimal upfront investment (OAC). DTC enables clinics to seamlessly incorporate testing services into their existing offerings with ease and flexibility. 

Providers can choose from a variety of non-invasive, quick, and reimbursable tests that align perfectly with their practice management. This level of customization not only improves diagnostic accuracy and patient outcomes but also opens new revenue streams through specialized, in-house diabetes testing, all while minimizing financial risk. This approach ensures that clinics can meet the unique needs of their patient populations efficiently. 

For investors, supporting DTC is a strategic move into a future where personalized care becomes the standard, and where their contributions drive meaningful change in healthcare. This is more than just an investment in technology—it is an investment in yourself and the broader impact you can have with your patients.

Zero Down Up to 90 Days (OAC)

Identify Health Risks 

Diabetes Testing Centers™ offers a range of comprehensive provider bundles tailored to the specific assessments and therapies for various medical specialties. Each bundle is designed to integrate seamlessly into existing workflows, ensuring that providers can offer targeted, effective care without disruption. This approach helps address the unique needs of patients with diabetes and related conditions, enhancing overall health outcomes.

Each bundle is crafted to seamlessly integrate into existing workflows, enabling providers to deliver targeted, effective care without interruption. This approach is tailored to meet the unique needs of patients managing diabetes and related conditions, which are often associated with significant morbidities and mortalities that can go unchecked. By incorporating comprehensive assessments and management tools across various medical specialties:

• Primary Care: Comprehensive diabetes assessments and management tools.

• Cardiology: Heart health monitoring and risk assessments.

• Endocrinology: Hormonal and metabolic evaluations.

• Neurology: Neuropathy and cognitive assessments.

• Ophthalmology: Eye health evaluations to detect diabetic retinopathy.

• Podiatry: Diabetic neuropathy foot care and wound management.

These efforts aim to identify and address these conditions early, leading to improved health outcomes and more efficient care delivery. This efficiency ensures that healthcare providers' time and resources are used effectively, enhancing the overall care experience.

Reduce Morbidities and Mortalities

Long COVID Consequences

Cardiovascular disease is the leading cause of death for both men and women, posing a significant risk to diabetes patients, as heart attacks and strokes can be fatal and overshadow other diabetes-related conditions. The risk is even higher for individuals who have had COVID-19, as the virus can worsen cardiovascular issues, leading to complications like myocarditis and blood clots. Therefore, testing for cardiovascular risk factors is critical for early identification and management, which can help prevent life-threatening events such as heart attacks or strokes.

The CardioANS™ test, used by healthcare providers, evaluates a patient’s risk of mortality and major adverse cardiovascular events (MACE). This test graphs the heartbeat through systolic and diastolic cycles, tracking deviations in fingertip pressure caused by arterial stiffness. Using a proprietary algorithm, it accurately assesses arterial hardening by analyzing pulse wave variations against extensive research data.

For individuals with Long COVID, especially those with cardiovascular symptoms, primary care testing is crucial to determine if comprehensive imaging, such as echocardiograms, is necessary to evaluate the left ventricle. Monitoring the left ventricle is essential for developing interventions to address the virus’s lasting cardiovascular effects. Additionally, cognitive assessments should be performed to address "brain fog" in post-COVID patients.

Key features of the CardioANS™ test:

• 3-minute non-invasive assessment

• Measures overall cardiovascular risk factors (heart attack and stroke)

• Assesses left ventricle ejection and contraction power

• Evaluates mental stress, physical stress, and resistance to stress

Left ventricular systolic dysfunction (LVSD) increases heart failure risk nearly 5x compared to normal function 

Kannel WB, Gordon T, and National Heart Institute (U.S.) (1968) The Framingham study: An epidemiological investigation of cardiovascular disease. Bethesda, MD., United States. Department of Health, Education, and Welfare, National Institutes of Health.

Sleep Medicine

Before ordering a home sleep test (HST), medical providers should consider ApneaReliefMD™, a customized, non-surgical alternative for managing both habitual snoring and obstructive sleep apnea separately, using our FDA Cleared medical deice and Oral Appliance Therapy (OAT). Patients will complete the program at home using two technologies. The first is the SnoreLab app, which records and tracks snoring patterns to identify potential sleep issues. The second is our oral appliance therapy (OAT), for managing snoring, mild, and moderate sleep apnea that must be prescribed by a medical provider. This approach provides a streamlined treatment, allowing for rapid and accurate screening through the SnoreLab app and offering effective therapy setup in just 15 minutes with our oral appliance. This integrated approach enhances patient outcomes and optimizes primary care practices. 

• Improves Glycemic Control: Enhances sleep quality, stabilizing blood sugar levels.

• Reduces Cardiovascular Risks: Mitigates common cardiovascular complications in diabetes.

• Enhances Insulin Sensitivity: Better sleep improves insulin sensitivity.

• Decreases Inflammation: Reduces systemic inflammation, beneficial for diabetic patients.

• Boosts Overall Quality of Life: Better sleep leads to improved energy, mood, and well-being.

This integrated approach significantly enhances patient outcomes by providing timely and effective diagnosis and treatment, while also optimizing primary care practices through streamlined workflows, improved patient management, and more efficient use of resources. This not only leads to better health results for patients but also allows primary care providers to deliver higher quality care with increased satisfaction for both patients and healthcare professionals.

Silent, Comfortable, and Portable

First, Do No Harm.

Discover the benefits of Oral Appliance Therapy (OAT) as a comfortable, portable, and quiet alternative to CPAP for mild and moderate obstructive sleep apnea (OSA)—enhance patient compliance and achieve better results with this effective, first-line therapy. Start improving your patients' sleep health today! 

Medical providers are instrumental in assisting patients with managing Obstructive Sleep Apnea (OSA) by prioritizing patient comfort and ease of use. By doing so, they help ensure patients stay engaged in their treatment. One approach is to begin with an affordable prefabricated oral appliance for a 1-2 week titration period before contemplating the use of a customized lab-made oral appliance. This method allows for a gradual and cost-effective approach to finding the most suitable and effective treatment for the individual patient.

CPAP Failures Harms Patients with OSA